S. 3716 · 119th Congress (2025–2027)
RARE Act
A bill to set forth limitations on exclusive approval or licensure of drugs designated for rare diseases or conditions.
CRS summary not yet available.
Referred to committee
Latest actionReferred to committee
This bill’s path
This is S. 3716’s recorded path, not a universal congressional workflow.
How bills become lawAll actionsIntroduced
Passed Senate
Passed House
Sent to President
Signed into law
- Sponsor
- Sen. Tammy Baldwin (D-WI)
- Policy area
- Health
On this page
Timeline
i
In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.
Introduced in Senate
Document: Introduced in Senate
Sources
- Congress.gov action
- Library of Congress
- Latest
Referred to committee
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Sources
- Congress.gov action
- Senate
Committees
Text & titles
i
Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.
| Version | Date | Links |
|---|---|---|
| Introduced in Senate |
Titles (3)
RARE Act
Display title, Short title · Introduced in Senate
Retaining Access and Restoring Exclusivity Act
Short title · Introduced in Senate
A bill to set forth limitations on exclusive approval or licensure of drugs designated for rare diseases or conditions.
Official title · Introduced in Senate